191 results on '"Héry-Arnaud G"'
Search Results
2. Epidemiology and clinical characteristics of Klebsiella spp. meningitis in France
3. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center
4. Une 2e année réussie pour Mycocare, l’action d’accompagnement des patients traités pour une infection à mycobactéries non tuberculeuses (MNT)
5. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry
6. Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study
7. Les mycobactéries non tuberculeuses
8. Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS)
9. Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning.
10. Un 1er bilan réussi pour Mycocare, l’action d’accompagnement des patients traités pour une infection à mycobactéries non tuberculeuses (MNT)
11. Infection bactérienne à Streptococcus gallolyticus transmise par transfusion d’un concentré de plaquettes : à propos d’un cas
12. Probiotics: A new way to fight bacterial pulmonary infections?
13. WS13.03 Real-world relevancy of qPCR for early detection of Pseudomonas aeruginosa infection in people with cystic fibrosis (pwCF)
14. Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study
15. Erratum to “Filifactor alocis bacteremia associated with facial cellulitis” [Infect. Dis. Now 52 (2) (2022) 119–120]
16. Filifactor alocis bacteremia associated with facial cellulitis
17. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints
18. Mycocare : prise en charge des patients traités pour une infection à mycobactéries non tuberculeuses
19. Intranasal or oral Lactobacilli administration: Which one is best for fighting against Pseudomonas aeruginosa (PA) respiratory tract infections?
20. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints
21. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints
22. Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS)
23. JACIE recommendations for microbiological environmental surveillance in haematopoietic cell transplant units
24. Global warming and planetary health: An open letter to the WHO from scientific and indigenous people urging for paleo-microbiology studies
25. P076 Pulmonary anaerobes as guardians of respiratory function in patients with cystic fibrosis (ANA-MUCO study)
26. S08.3 Novel characterisation of the lung microbiome in cystic fibrosis patients and longitudinal changes associated with Pseudomonas aeruginosa early colonisation
27. ePS6.08 Intranasal or oral Lactobacilli administration: which one is best for fighting against Pseudomonas aeruginosa respiratory tract infections?
28. P095 Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis centre
29. P078 An improved bioinformatic pipeline for cystic fibrosis lung microbiome characterisation
30. Fatal congenital tuberculosis due to a Beijing strain in a premature neonate
31. Intrafamilial transmission of extended-spectrum-β-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children
32. Méningite bactérienne à Capnocytophaga canimorsus
33. Epidemiology and clinical characteristics of Klebsiellaspp. meningitis in France
34. Helicobacter cinaedi associated with atypical Raynaud syndrome
35. Abcès pulmonaire à Gallibacterium anatis
36. Porphyromonas, a neglected potential key genus of the lung microbiota: description in patients with cystic fibrosis (CF)
37. EPS4.02 Porphyromonas, a candidate biomarker for detection of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis
38. L’administration intranasale de Lactobacillus : un moyen efficace de protéger des infections pulmonaires à P. aeruginosa ?
39. Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study
40. 169 Switching of airway microbiota in patients with cystic fibrosis (CF): should Pseudomonas aeruginosa plead guilty?
41. High resolution melting PCR et mucoviscidose, un voyage au laboratoire
42. ePS03.7 Rosco-CF, a safety and efficacy clinical trial of (R)-roscovitine in CF patients
43. WS07.3 Pulmotypes of airway microbiota in the early stages of Pseudomonas aeruginosa (Pa) colonization in cystic fibrosis: a cohort study
44. Infection pulmonaire à Mycobacterium abscessus sensu lato chez des patients exempts de mucoviscidose
45. WS14.1 ROSCO-CF, a safety and efficacy clinical trial of (R)-roscovitine in cystic fibrosis patients
46. Impact d’un avis infectiologique spécialisé sur la prise en charge des bactériémies vraies
47. Proficiency of PCR in hospital settings for nonculture diagnosis of invasive meningococcal infections
48. Infection pulmonaire à mycobacterium abscessus sensu lato chez les patients non mucoviscidosiques
49. Infection à mycobactérie atypique chez les patients non mucoviscidosiques : adéquation de diagnostic et de traitement
50. 103 Bacterial diversity and dynamics during the early stages of Pseudomonas aeruginosa colonization in cystic fibrosis airways
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.